GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Construction In Progress

Chenguang Biotech Group Co (SZSE:300138) Construction In Progress : ¥162 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co Construction In Progress?

Chenguang Biotech Group Co's quarterly construction in progress increased from Sep. 2023 (¥276 Mil) to Dec. 2023 (¥295 Mil) but then declined from Dec. 2023 (¥295 Mil) to Mar. 2024 (¥162 Mil).

Chenguang Biotech Group Co's annual construction in progress declined from Dec. 2021 (¥220 Mil) to Dec. 2022 (¥183 Mil) but then increased from Dec. 2022 (¥183 Mil) to Dec. 2023 (¥295 Mil).

Chenguang Biotech Group Co Construction In Progress Historical Data

The historical data trend for Chenguang Biotech Group Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co Construction In Progress Chart

Chenguang Biotech Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.67 204.12 219.84 183.42 295.48

Chenguang Biotech Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 173.30 203.09 275.67 295.48 161.70

Chenguang Biotech Group Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Chenguang Biotech Group Co (SZSE:300138) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Construction In Progress
Comparable Companies
SZSE:002124 SHSE:603363 SHSE:603668 SZSE:000735 SZSE:001313 SZSE:002746 SHSE:603609 SHSE:600313 SZSE:301116 SHSE:600108 ADM SZSE:002714 SZSE:300498 SHSE:600438 TSN BG OSL:MOWI OSL:SALM SZSE:000876 ISX:CPIN
Traded in Other Exchanges
N/A
Address
Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250
Website
http://www.cn-cg.com
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Executives
Li Feng Fei Executives
Zhou Jing Directors, Directors, and Executives
Li Yue Zhai Director
Lian Yun He Executives
Chen Yun Xia Executives
Zhao Tao Supervisors
Yuan Xin Ying Supervisors
Liu Zhang Lin Independent director
Lu Qing Guo Directors, executives
Zhou Fang Sheng Independent director
Wang Shu Hong Independent director
Liu Ying Shan Director
Han Wen Jie Executives
Liu Dong Ming Supervisors
Yang Wen Fang Supervisors

Chenguang Biotech Group Co (SZSE:300138) Headlines

No Headlines